Feasibility of dc vaccine combined with low dose endoxan and high dose il-2 treatment associated with taurolidine for advanced, multi-resistant melanoma patients.

Journal for ImmunoTherapy of Cancer - Tập 3 - Trang 1-1 - 2015
Gustavo A Moviglia1, Ralf Kleef2
1Maimonides University, Ciudad de Buenos Aires, Argentina
2Maimonides University, Vienna, Austria